Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

We cannot be complacent about drug resistant bacteria

Christopher Johnson, MD
Conditions
January 22, 2013
Share
Tweet
Share

This little cartoon, courtesy of xkcd, highlights a problem we have had for some time, but which is getting worse–highly antibiotic-resistant bacteria. Soon after the first antibiotics appeared, especially penicillin, doctors noticed the phenomenon of developing bacterial resistance to them. The cause is evolution in action. The replication time for bacteria is extremely fast, as short as twenty minutes in some cases. So the process of evolution, of random mutation and passing new traits on to offspring, happens in minutes rather than years.

Say a population of bacteria is 99.99% susceptible to being killed by an antibiotic, or sensitive. When the antibiotic has done its work there are 0.01% of the bacteria left. If their resistance to the antibiotic is heritable, they will pass that on to their offspring. Before too long, if the antibiotic is still present in the system and nothing else intervenes, all of the bacteria will be resistant. An important thing that can intervene is that the body has its own ways of killing bacteria on its own without the help of antibiotics. If the burden of infection is low, as when antibiotics kill nearly all the bacteria, our natural infection-fighting system can do the rest.

It’s been known for a long time how to at least slow down the process of bacteria acquiring antibiotic resistance — limit the use of antibiotics to when they are really needed, and use the ordinary, simple antibiotics whenever possible. So if a germ is sensitive to many antibiotics, which is often the case, use the simple one. This reserves our newest, most powerful drugs for when we really need them, which is when they are the only ones to which the germ is sensitive. In addition, don’t use antibiotics when they don’t do any good, such as with viral infection.

A recent article in the New England Journal of Medicine, “Preventing lethal hospital outbreaks of antibiotic-resistant bacteria,” describes how we are doing. It is a vital question, because bacteria resistant to many, and sometimes all, antibiotics are killers. It’s a particular problem in hospitals, which you can think of as gathering together many sick and vulnerable people in one spot. It’s a set-up for disaster if a highly resistant bacterial strain gets loose, and is why hospitals themselves can be dangerous places — you can acquire an infection there you didn’t come in with, called nosocomial infections. Reducing the problem means limiting the use of antibiotics only to those cases in which they are really necessary and choosing the correct antibiotic. It also means strict isolation and handwashing techniques for caregivers of patients infected with these bacteria to limit the spread to others.

This problem is not going to go away. It will probably get worse. Although researchers are always working to develop new antibiotics to stay one jump ahead of the bacteria, we can’t count on this approach, either.

Antibiotics have been miracle drugs since the 1940s, saving millions of lives. If we are complacent about the issue of resistance, we will be back in the dark days before that.

Christopher Johnson is a pediatric intensive care physician and author of Your Critically Ill Child: Life and Death Choices Parents Must Face, How to Talk to Your Child’s Doctor: A Handbook for Parents, and How Your Child Heals: An Inside Look At Common Childhood Ailments.  He blogs at his self-titled site, Christopher Johnson, MD.

Prev

When is making the decision to be DNR appropriate?

January 22, 2013 Kevin 4
…
Next

Do patient portals increase patient engagement?

January 22, 2013 Kevin 12
…

Tagged as: Infectious Disease

Post navigation

< Previous Post
When is making the decision to be DNR appropriate?
Next Post >
Do patient portals increase patient engagement?

ADVERTISEMENT

More by Christopher Johnson, MD

  • The success of Australian firearms regulation: What it could mean for children

    Christopher Johnson, MD
  • Do protocols and pathways improve care?

    Christopher Johnson, MD
  • Why are so many community hospitals transferring children to larger facilities?

    Christopher Johnson, MD

More in Conditions

  • Medicaid lags behind on Alzheimer’s blood test coverage

    Amanda Matter
  • Why transgender health care needs urgent reform and inclusive practices

    Angela Rodriguez, MD
  • Why the Sean Combs trial is a wake-up call for HIV prevention

    Catherine Diamond, MD
  • New surge in misleading ads about diabetes on social media poses a serious health risk

    Laura Syron
  • mRNA post vaccination syndrome: Is it real?

    Harry Oken, MD
  • The critical role of nurse practitioners in colorectal cancer screening

    Elisabeth Evans, FNP
  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • An addiction physician’s warning about America’s next public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Gen Z’s DIY approach to health care

      Amanda Heidemann, MD | Education
    • What street medicine taught me about healing

      Alina Kang | Education
    • Smart asset protection strategies every doctor needs

      Paul Morton, CFP | Finance
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • How IMGs can find purpose in clinical research [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 2 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • An addiction physician’s warning about America’s next public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Gen Z’s DIY approach to health care

      Amanda Heidemann, MD | Education
    • What street medicine taught me about healing

      Alina Kang | Education
    • Smart asset protection strategies every doctor needs

      Paul Morton, CFP | Finance
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • How IMGs can find purpose in clinical research [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

We cannot be complacent about drug resistant bacteria
2 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...